%{{tag.tag}} {{articledata.title}} {{moment(articledata.cdate)}} @{{articledata.company.replace(" ","")}} comment A California-based %Healthcare company is causing quite the stir during Wednesday’s premarket after it was announced that the company was granted U.S. patent #11653972 for "Medical Systems And Methods For Resecting And Extracting Tissue", according to the release. Naturally this type of news causes traders to get excited, and they didn’t hesitate to bid up shares of %MinervaSurgical (Nasdaq: $UTRS ) early Wednesday morning. At the time of writing, traders are willing to buy shares at $0.58/share (+218.86% implied open for sellers). This should be an exciting session for this micro cap! Minerva Surgical Inc is a commercial-stage %MedicalTechnology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women.